Sander W Tas Selected Research

Sander W Tas Research Topics

Disease

18	Rheumatoid Arthritis 07/2023 - 01/2006
16	Inflammation (Inflammations) 01/2023 - 01/2006
11	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 06/2009
9	COVID-19 07/2023 - 01/2021
7	Neoplasms (Cancer) 09/2022 - 06/2009
7	Arthritis (Polyarthritis) 01/2022 - 01/2006
6	Rheumatic Diseases (Rheumatism) 01/2024 - 08/2020
4	Infections 05/2024 - 01/2021
4	Breakthrough Infections 05/2024 - 06/2022
4	Multiple Sclerosis 03/2024 - 01/2022
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2023 - 10/2021
3	Crohn Disease (Crohn's Disease) 01/2024 - 01/2020
3	Synovitis 01/2023 - 04/2008
2	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2021
2	Vasculitis (Vasculitides) 12/2021 - 10/2021
2	Atherosclerosis 01/2020 - 01/2018
2	Pathologic Neovascularization 01/2019 - 06/2018
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2018 - 01/2018
2	Experimental Arthritis 08/2006 - 01/2006
1	Muscular Diseases (Myopathy) 01/2024
1	Post-Acute COVID-19 Syndrome 07/2023
1	Fatigue 07/2023
1	Axial Spondyloarthritis 01/2023
1	Psoriatic Arthritis 01/2023
1	AIDS-Related Complex (ARC) 06/2022
1	Spondylitis 01/2022
1	Osteitis 11/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hypersensitivity (Allergy) 01/2020

Drug/Important Bio-Agent (IBA)

6	AntibodiesIBA 05/2024 - 09/2015
6	Phosphotransferases (Kinase)IBA 01/2019 - 11/2014
5	Immunosuppressive Agents (Immunosuppressants)IBA 05/2024 - 01/2022
5	Etanercept (Enbrel)FDA Link 07/2023 - 08/2020
5	Immunomodulating AgentsIBA 05/2023 - 01/2015
5	Adalimumab (Humira)FDA Link 03/2023 - 01/2020
5	CytokinesIBA 12/2021 - 08/2006
4	AntigensIBA 07/2023 - 04/2008
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2023 - 01/2019
3	AutoantibodiesIBA 01/2024 - 09/2015
3	Rheumatoid FactorIBA 01/2024 - 09/2015
3	Rituximab (Mabthera)FDA Link 11/2023 - 01/2019
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 03/2023 - 01/2018
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2018
3	tocilizumab (atlizumab)FDA Link 01/2022 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Oxygen (Dioxygen)IBA 01/2022 - 02/2016
3	LipidsIBA 01/2020 - 07/2013
3	NF-kappa B (NF-kB)IBA 06/2009 - 01/2006
2	ocrelizumabIBA 03/2024 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2024 - 11/2021
2	Immunoglobulin M (IgM)IBA 01/2024 - 09/2015
2	COVID-19 VaccinesIBA 05/2022 - 11/2021
2	GlucocorticoidsIBA 01/2022 - 01/2021
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2021 - 10/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2018 - 11/2014
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2015 - 01/2015
2	I-kappa B KinaseIBA 08/2006 - 01/2006
1	Monoclonal AntibodiesIBA 03/2024
1	HLA-DR Antigens (HLA-DR)IBA 03/2024
1	Messenger RNA (mRNA)IBA 03/2024
1	EpitopesIBA 01/2024
1	upadacitinibIBA 01/2024
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024
1	Infliximab (Remicade)FDA Link 07/2023
1	vedolizumabIBA 07/2023
1	Antiviral Agents (Antivirals)IBA 03/2023
1	AutoantigensIBA 01/2023
1	IgG Receptors (Fc gamma RI)IBA 01/2023
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	baricitinibIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Folate Receptor 2IBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	tofacitinibIBA 01/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022
1	Immunoglobulin A (IgA)IBA 11/2021
1	VaccinesIBA 11/2021
1	Methotrexate (Mexate)FDA LinkGeneric 11/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020

Therapy/Procedure

13	Therapeutics 11/2023 - 10/2015
2	Immunotherapy 09/2022 - 06/2009
2	Immunomodulation 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 06/2009
1	Transjugular Intrahepatic Portasystemic Shunt 01/2024
1	Injections 07/2023